The relationship between ABO-Le secretor phenotype and susceptibility to recurrent idiopathic vulvovaginal candidiasis (RVVC) was investigated. ABO and Lewis blood typing was done for 38 women with RVVC (case-patients) and for women in 2 control groups, consisting of 58 healthy women, who were friends identified by case-patients, and 38 race-matched, healthy hospital employees. The 3 groups were similar with regard to age and race. There was no difference in the distribution of ABO phenotype between case-patients and controls. Case-patients were more likely than members of either control group to have Le(a/b0) (nonsecretor) rather than Le(a0b/) (secretor) blood type. With combined nonsecretor Le(a/b0) phenotype and absence of the Lewis gene Le a0b0 , the relative risk of chronic recurring vulvovaginal candidiasis was 2.41 -4.39, depending on the analysis technique and control group. In conclusion, there is an increased frequency of ABO-Le nonsecretor status among women with RVVC.
The etiology of recurrent vulvovaginal candidiasis remains
antigens. H antigen is present in body fluids of secretors of the ABO blood groups, and in 94% of the secretors, there will also unknown. Only rarely are secondary precipitating or underlying be Le(a) and Le(b) antigen. Although vaginal epithelia from contributory factors identified [1] .
women with recurrent candidal vaginitis have not shown inThe first step in vaginal mucosal colonization by Candida creased cell affinity for adherence of Candida species in vitro species is adherence to the vaginal epithelial cells [2] . Fucose,
[6], we hypothesized that secretor status could influence suswhich inhibits in vitro binding of yeast to human vaginal epiceptibility to vaginal colonization by Candida fungi. Bufordthelial cells [3 -5] (47) 21 (36) 16 (42) confirmed episode of acute VVC, history of more than three con-AB 2 (5) 4 (7) 4 (11) firmed episodes of VVC during the year prior to being placed on antimycotic maintenance therapy at the clinic, and development
Le(a/b0) 13 (34) 8 (14) 6 (16) of a symptomatic culture-proven episode of VVC while on mainte-
18 (47) 44 (76) 26 (68) nance antifungal therapy (fluconazole, 100 mg/week; clotrimazole, Le(a0b0) 7 (18) 6 (10) 6 (16) 500 mg/week) or a relapse of symptomatic and culture-proven with mixed infections, including bacterial vaginosis and trichomoniasis, were excluded. Data analysis. Data were entered using Microsoft Excel [9] . Patient population. Thirty-eight women meeting the case SAS software (SAS Institute, Cary, NC) was used for data managedefinition were identified (case-patients). Because the clinic is a ment and analysis [10] . Exact 95% confidence intervals were calcutertiary clinic, it is difficult to determine the underlying population lated around crude odds ratios, using Epi Info (version 6.0; CDC, for study. Therefore, we established 2 control groups: One conAtlanta) [11] . For the matched-pair analysis, we calculated the sisted of friends of the case-patients; the other consisted of hospital Mantel-Haenszel summary odds ratio, test-based confidence interemployees. It was assumed that friends would be similar with vals, and the Logit estimator with precision-based confidences respect to sociodemographic status and behavior, including use of intervals, using SAS software [10] . medical services, and would therefore reflect the underlying study population. Each case-patient was asked to identify 3 female
Results
friends for participation in the study. Friends meeting study criteria were interviewed by telephone; blood samples were obtained from Most case-patients (95%), friend controls (98%), and hospithe women either at the clinic or in their homes. Hospital employtal employee controls (95%) were white. Cases were slightly ees provide a convenience sample of healthy women for compariolder (mean age, 39 { 10 years) than either friend controls son and have been used in similar studies. Female hospital employ-(mean, 38.7 { 8.7) or hospital employees (mean, 37.6 { 8.1), ees of the same age and race as case-patients were asked to but the differences were not statistically significant.
volunteer; blood samples were collected from those meeting eligiThere was no difference in the distribution of ABO phenobility criteria.
type between case-patients and either control group (table 1).
Methods. An antecubital vein blood sample was obtained for However, the distribution of Lewis phenotype was statistically ABO and Lewis blood group phenotyping from each study particidifferent between case-patients and friend controls, with casepant. A clotted specimen of whole blood (red tube) was properly patients being more likely to have Le(a/b0) (nonsecretor) labeled and centrifuged for 2 min at high speed. The serum was than Le(a0b/) (secretor) blood group (x 2 , P Å .015). The removed and placed in a second labeled tube. ABO phenotyping distribution of Lewis phenotype among hospital employees was (forward and reverse typing) was done by macroscopic hemagglusimilar to that for friend controls; however, it was not statistitination: one drop of anti-A, anti-B, and anti-A, B, (Immucor, cally significantly different from that for case-patients (P Å Norcross, GA) was added to a 4% test cell suspension, which was then centrifuged for 20 s at high speed.
.12), probably because there were only 38 hospital employees, Le(a) and Le(b) phenotyping were done by use of anti-Le(a) compared with 58 friend controls. as 21% of chronic recurring vulvovaginal candidiasis (67% 1 32%). Further studies should examine whether mucosal surface differences as well as those in vaginal secretions explain the susceptibility of some women to repeated bouts of vaginal nonsecretor phenotype, Le(a/b0) or Le(a0b0). In both concandidiasis in the absence of other known predisposing factors. trol groups, secretor phenotype, Le(a0b/), predominated. Our results are similar to those of Hilton et al. [8] ; however, they
